
Bioventus Inc.
USD11.88
+0.30 (+2.59%)
CEO
Robert Claypoole
IPO Date
2021-02-11
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$11.47
Prev. Close
$11.58
Day Low
$11.40
Day High
$11.91
52W Low
$5.81
52W High
$12.53
Market Cap
$0.80B
Volume
0.45M
| 6 Mar 2026 |
| Barrington Research |
| Outperform |
| Outperform |
| maintain |
| 6 Mar 2026 | Craig-Hallum | Buy | Buy | maintain |
| 17 Mar 2025 | Canaccord Genuity | Buy | Buy | maintain |
| 17 Dec 2024 | JP Morgan | Underweight | Neutral | upgrade |
| 6 Nov 2024 | Canaccord Genuity | Buy | Buy | maintain |
| 27 Sept 2024 | Craig-Hallum | Buy | Buy | maintain |
| 13 Aug 2024 | Canaccord Genuity | Buy | Buy | maintain |